Not exact matches
NewLink Genetics» stock price cratered more
than 32 %
in early Thursday trading after Roche arm Genentech told the company it would be returning the rights to NewLink's experimental
cancer treatment navoximod.
Drugmaker Merck reported a better -
than - expected first - quarter profit on Tuesday, helped by a more
than 150 percent rise
in sales of
cancer drug Keytruda.
U.S. drug giant Merck is paying $ 300 million
in a deal possibly worth more
than $ 5 billion to partner Eisai
in an effort to boost its star
cancer immunotherapy treatment Keytruda, which could match up well
in a combination with Eisai's Lenvima.
There are more
than 80 immune - related
cancer therapies currently
in clinical trials, fueled by many billions of dollars
in pharmaceutical investment from the likes of Bristol - Myers Squibb bmy, Merck mrk, Pfizer pfe, and dozens of biotechs.
A panel of three entrepreneurs discussed the relationship between purpose and profitability
in greater depth: Pocket Sun, who, as founding partner of female - focused VC firm SoGal Ventures, has a purpose of «building an empire for millennial women to invest
in startups»; Eileen Gittins, a serial entrepreneur who founded book self - publishing firm Blurb and now runs Bossygrl, a mobile app meant to introduce Gen Z girls to entrepreneurship by helping them launch micro-businesses; and Cathie Reid, co-founder and current digital advisor to Icon Group, an Australian
cancer - care company with annual revenue of more
than $ 1.5 billion.
It's the first time the agency has approved a drug that targets
cancer based on a tumor's genetic traits, rather
than where it is located
in the body.
The status quo for hundreds of thousands of people, meanwhile, is untenable: More
than 333,000 Americans will be diagnosed this year
in any of four
cancer types
in which the five - year survival rate remains lower
than 20 %, and
in all, nearly 600,000 U.S. deaths are expected from
cancer in 2016.
The yearly confab is the biggest
cancer conference
in the world, attracting more
than 30,000 oncology researchers, biopharma executives, investors, and public health experts.
Non-Hispanic black (NHB) women «continued to have higher breast
cancer death rates
than [non-Hispanic white] women, with rates 39 % higher
in NHB women
in 2015, although the disparity has ceased to widen since 2011.»
Because it makes up more
than 13 % of all new
cancers and nearly 27 % of all
cancer deaths
in the U.S. Just 17.7 % of diagnosed patients are still alive five years out from their diagnosis.
Martin Shkreli, unaffectionately known as the «pharma bro» — and infamous for his decision to hike the list price of Daraprim, a drug used by HIV / AIDS and
cancer patients to combat infections, by more
than 5,000 %
in 2015 under his former company Turing Pharmaceuticals — was convicted on three criminal securities fraud and conspiracy charges by a Brooklyn jury on Friday.
• Grail, a life sciences company focused on early
cancer detection that operates as a subsidiary of Illumina Inc. (Nasdaq: ILMN), raised more
than $ 900 million
in Series B funding.
Your chances of surviving cardiac arrest — which can strike
in healthy people, and kills more Americans each year
than Alzheimer's, breast
cancer, cervical
cancer, colorectal
cancer, diabetes, HIV, car crashes, prostate
cancer, and suicides combined — vary immensely based on your zip code.
The International Agency for Research on
Cancer agrees with California on this one: diesel oil has more than 30 known components that can cause cancer, though in a well - ventilated parking deck, there shouldn't be too many
Cancer agrees with California on this one: diesel oil has more
than 30 known components that can cause
cancer, though in a well - ventilated parking deck, there shouldn't be too many
cancer, though
in a well - ventilated parking deck, there shouldn't be too many fumes.
But again, the FDA says the levels of the chemical
in foods like fries or crackers are much lower
than acrylamide levels linked to
cancer in animal studies.
Last year, the CDC found that U.S. life expectancy had actually dropped for the first time
in more
than two decades to an average of 78.8 years and that every major leading cause of death other
than cancer was killing more people.
But
in medicine, impressive technology is little more
than a parlor trick if it doesn't benefit patients — like James (who asked to keep his last name private), a 42 - year - old colon
cancer patient who had part of his large intestine removed by Sullivan a few months ago.
But the 23rd annual Sohn Investment Conference — held
in memory of Ira Sohn, and benefiting pediatric
cancer research and treatment — had a larger -
than - usual contingent of technology investors, and not everyone agreed with Gundlach's stance.
When lung
cancer claimed Nathalie Estime's husband, Roger Ndeffo,
in 2007, she lost more
than her life partner — she lost her sense of purpose.
One setback for these therapies which use the body's immune system to fight
cancers is that they are, at times, more effective
in certain patient pools
than others.
In the last of those years, the reporters discovered, the federal government actually spent more on urine - based drug tests
than it did on «the four most recommended
cancer screenings combined.»
The study, just published
in Science, showed that the creation of what the researchers are calling microtumors can help predict drug effectiveness
in cancer patients better
than the current standard method of testing the drugs on rodents.
That's not just because of Opdivo's failure — last month, Keytruda was shown to be better
than standard chemotherapy
in untreated advanced lung
cancer patients with high levels of the PD - L1 protein, both stopping
cancer progression and extending patients» lives.
«Nothing could be more important
than precisely identifying DNA code alterations that drive the
cancers» growth and use that information to decide on treatment plan,» Dr. Stephane Richard, CEO, shared with me
in email.
In a clinical trial of more
than 600 participants, Empliciti, when used with
cancer drug Revlimid and steroid dexamethasone was better at delaying when the
cancer worsened
than just the two drugs alone.
We managed to stop putting a hole
in the ozone layer by phasing out the chemicals that were causing it (cholofluorocarbons) and, as a result, the hole is closing and there are millions fewer cases of skin
cancer than there would otherwise have been.
Smoking is one of the single biggest risk factors for lung
cancer, which makes up more
than 13 % of all new
cancer diagnoses and more
than one
in four
cancer deaths
in the U.S.
They suggest most women
in their 40s should not have routine mammograms because the tests may cause more harm
than good because of false positive results (follow - up testing proves negative for
cancer).
One study that looked at more
than 5,000 brain
cancer cases
in 13 countries found no increase
in risk related to phone use, though it called for more research on the topic.
This method has proven most effective
in blood
cancers (rather
than solid tumors) such as leukemias and lymphomas.
More
than 35,000 oncologists, researchers, life science executives, and other stakeholders flocked to the world's largest
cancer conference between June 3 and 7 to discuss the most exciting new advances
in the field.
And the fact that it's happening
in more
than one
cancer is definitely interesting,» Higginbotham told Business Insider.
The IARC evaluates substances suspected of causing
cancer in humans, and arrives at its classifications by convening a working group of international experts to review and assess the strength and quality of the evidence —
in this case, more
than 800 studies.
Blankfein, who underwent chemotherapy for
cancer more
than two years ago, led the firm through the financial crisis
in better shape
than most rivals, and the company capitalized with record trading revenues.
In the case of Scottish salmon, they recommended that those who wish to avoid
cancer - causing chemicals have no more
than three farmed - salmon meals a year.
The Canadian Trade Office
in Taiwan organized the 5th annual Terry Fox run
in Taipei and more
than 7,000 runners participated to raise funds for
cancer research.
BioNTech, which has around 700 employees at sites
in Germany — more
than any other unlisted biotech firm
in Europe — is also working on other
cancer - fighting technologies, including antibodies, cell therapies and small molecules.
The American
Cancer Society estimates lung cancer will cause more than 234,000 new cases this year in the U.S. and more than 154,000 d
Cancer Society estimates lung
cancer will cause more than 234,000 new cases this year in the U.S. and more than 154,000 d
cancer will cause more
than 234,000 new cases this year
in the U.S. and more
than 154,000 deaths.
A glut of liquid biopsy companies have emerged from universities and elsewhere
in recent years to catch
cancer by relying on a patient's DNA, rather
than having to extract their tissue.
HERERA: Merck (NYSE: MRK) was one of the best performing stocks on the blue chip Dow index today, after the drug company «s new type of lung
cancer drug performed better
than expected
in a highly anticipated clinical trial.
U.S. health regulators on Tuesday granted accelerated approval for Pfizer Inc's immuno - oncology drug Bavencio to treat advanced bladder
cancer, marking the second approval
in less
than two months for the treatment developed along with Germany's Merck KGaA.
They'll also jointly market Pfizer's drug Xalkori, which is approved
in more
than 75 countries for treating non-small cell lung
cancer in patients with a certain genetic mutation.
The drug already has undergone initial testing
in more
than 550 patients with multiple types of
cancer.
That as a society we are okay with the idea that you can't purchase a television, we're okay with the idea that you can't purchase a nice couch, but we're not okay with the idea on some fundamental level that you get
cancer and you can't pay for care, or even lower
than that, that you break your leg and you can't get it put
in a cast by a reputable doctor.
Executives at SAP and Nvidia said they hoped genetic screening might ultimately help prevent at least a few late - stage
cancers, the kinds of life - threatening illnesses that can debilitate employees and cost companies with self - funded health plans more
than $ 1 million
in medical fees.
It is hoped this means of treating
cancer will be more successful and result
in far less debilitating side effects
than chemotherapy.
In 2016, opioids killed more Americans
than breast
cancer.
Looking at sixty - seven recent drug discovery projects based on preclinical
cancer biology research, they found that
in more
than 75 percent of cases the published data did not match up with their
in - house attempts to replicate.
My dear friend who died
in less
than 18 months from aggressive breast
cancer was told by the vicar to apologise to the church committee about a minor matter or «consider her future as a member» (I helped her prepare her reply and told her that she couldn't say what she wanted to say, she was insistent but I was emphatic «it's not the content....
At last,
in his desperation, the question hit him: «Well, how much better off am I
than a
cancer patient?